| pubmed-article:16380757 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16380757 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:16380757 | lifeskim:mentions | umls-concept:C0014507 | lld:lifeskim |
| pubmed-article:16380757 | lifeskim:mentions | umls-concept:C0599755 | lld:lifeskim |
| pubmed-article:16380757 | lifeskim:mentions | umls-concept:C0337810 | lld:lifeskim |
| pubmed-article:16380757 | lifeskim:mentions | umls-concept:C0003872 | lld:lifeskim |
| pubmed-article:16380757 | lifeskim:mentions | umls-concept:C0683325 | lld:lifeskim |
| pubmed-article:16380757 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:16380757 | pubmed:dateCreated | 2005-12-28 | lld:pubmed |
| pubmed-article:16380757 | pubmed:abstractText | Because there is the impression that psoriatic arthritis is a composite disorder with mild forms close to more severe and aggressive ones, we conducted a multicenter study with the aim of characterizing disease expression in a large cohort of Italian patients. One-thousand-three-hundred-six patients fulfilled inclusion criteria and were analyzed in this study. Psoriasis antedated the onset of arthritis in the majority of the cases (67.7%). More rare was inverse or simultaneous onset which occurred in 17.3% and 15.0% of the cases, respectively. Peripheral articular involvement (mono-oligo or polyarthritis) was recorded in 88.7% of the cases while spondylitis occurred in 11.3%. Peripheral enthesopathies were found in 28.1% of the cases with a marked occurrence in patients with axial involvement (64.5% vs 35.5% in oligo or polyarthritis). Abnormal levels of ESR and CRP respectively occurred in 52.2% and in 52.6% of the cases, while rheumatoid factor was detected in 5.0% of the cases. On the basis of distribution of joint involvement, symmetry and presence of peripheral enthesopathies we recognized three clusters of arthritis. Patients included in Cluster 1 and Cluster 2 showed a severe form of polyarthritis in most of the cases (82.9%), with increased serum levels of inflammatory indices in more than 85% of the cases. Almost all the hospitalized patients (97.1%) were included in this two clusters. They markedly assumed steroids and methotrexate or another DMARD. About half of the patients (51.1%) included in Cluster 3 showed mono-oligo articular involvement. Serum inflammatory indices were increased in 20.8% of the cases while hospitalization occurred only in 2.9% of the cases and NSAIDs were the treatment of choice. The evidence in our country of a large prevalence of severe forms of arthritis needing specific and aggressive approach outlines the requirement of an intense educational action aimed at increasing the awareness of this condition. | lld:pubmed |
| pubmed-article:16380757 | pubmed:language | ita | lld:pubmed |
| pubmed-article:16380757 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16380757 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16380757 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16380757 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16380757 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16380757 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16380757 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16380757 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16380757 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16380757 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:16380757 | pubmed:issn | 0048-7449 | lld:pubmed |
| pubmed-article:16380757 | pubmed:author | pubmed-author:MathieuAA | lld:pubmed |
| pubmed-article:16380757 | pubmed:author | pubmed-author:PunziLL | lld:pubmed |
| pubmed-article:16380757 | pubmed:author | pubmed-author:CerviniCC | lld:pubmed |
| pubmed-article:16380757 | pubmed:author | pubmed-author:ScarpaRR | lld:pubmed |
| pubmed-article:16380757 | pubmed:author | pubmed-author:LeardiniGG | lld:pubmed |
| pubmed-article:16380757 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16380757 | pubmed:volume | 57 | lld:pubmed |
| pubmed-article:16380757 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16380757 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16380757 | pubmed:pagination | 283-90 | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:meshHeading | pubmed-meshheading:16380757... | lld:pubmed |
| pubmed-article:16380757 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16380757 | pubmed:articleTitle | [Psoriatic arthritis: epidemiological and clinical aspects in a cohort of 1.306 Italian patients]. | lld:pubmed |
| pubmed-article:16380757 | pubmed:affiliation | Clinica Reumatologica, Università di Ancona, Italia. | lld:pubmed |
| pubmed-article:16380757 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16380757 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:16380757 | pubmed:publicationType | Multicenter Study | lld:pubmed |
